Skip to main content
. 2016 May 10;11(5):e0155308. doi: 10.1371/journal.pone.0155308

Table 1. Demographic and clinical findings of the patients in this study.

Parameters Total # evaluated, % (N) EBV positive, % (N) p-value
Age Fisher’s exact Test
 < 5 years 52.8 (420/796) 33.8 (142/420/)
 5–15 years 32.5 (259/796) 26.3 (68/259) 0.039*
 > 15 years 14.7 (117/796) 18.8 (22/117) 0.002*
Gender
 Male 49.6 (395/796) 31.4 (124/395) 0.185*
 Female 50.4 (401/796) 26.9 (108/401)
Region of residence
 Lake Victoria basin 39.7 (316/796) 36.4 (115/316)
 Kisii highland 43.0 (342/796) 24.6 (84/342) 0.001*
 Coastal region 6.8 (54/796) 22.2 (12/54) 0.045*
 Semi-Arid region 10.6 (84/796) 25.0 (21/84) 0.051*
Symptomsa Odds Ratio
 Chills 46.7 (337/721) 47.6 (97/204) 0.948 0.98
 Cough 63.7 (506/794) 66.4 (154/232) 0.488 0.82
 Difficulty breathing 6.2 (49/790) 6.5 (15/231) 0.619 1.30
 Sore throat 26.5 (153/577) 23.7 (36/152) 0.385 0.76
 Headache 74.4 (409/550) 72.2 (104/144) 0.879 1.05
 Joint aches 34.2 (190/555) 34.3 (49/143) 0.463 1.30
 Rash 5.0 (39/775) 6.8 (15/221) 0.157 2.06
 Runny nose 50.5 (395/782) 56.6 (128/226) 0.162 1.49
 Eye pain 9.3 (70/751) 9.3 (20/214) 0.641 0.83
 Seizures 2.2 (17/775) 2.7 (6/225) 0.299 2.34
 Abdominal pain 46.2 (292/632) 41.4 (72/174) 0.216 0.72
 Vomiting 28.3 (224/792) 30.6 (70/229) 0.436 1.24
 Diarrhea 16.1 (128/795) 16.5 (38/231) 0.992 1.00
 Blood in stool 2.0 (16/785) 0.87 (2/229) 0.339 0.34
 Bleeding 1.5 (12/796) 1.3 (3/232) 0.736 0.67
 Muscle aches 19.9 (99/497) 21.2 (25/118) 0.78 1.11
 Jaundice 2.7 (18/674) 3.0 (6/195) 0.834 0.83
 Sputum production 7.5 (46/624) 8.7 (14/161) 0.599 0.78

The geometric mean ages of patients was 4 years (range: 1–80 years)

aData missing for some patients

←Referent category

*p-value calculated using Fisher’s exact test

Associations between clinical symptoms and EBV status were evaluated using multiple logistic regression